EUVIMEDEUVIMED entdecken
Crossref

Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Kyoung A Ko iD, Hyunwoo Oh, Myung Sub Kim, Hyun Pyo Hong, Yong Kyun Cho, Byung Ik Kim, Won Sohn iD

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Kyoung A Ko und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Kor…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Chemoembolization, Therapeutic, Bilirubin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study investigated the role of the albumin–bilirubin (ALBI) grade as a predictive factor for mortality in patients with favorable liver function undergoing transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).

Methods

A total of 251 HCC patients with Child–Pugh class A and a model for end‐stage liver disease (MELD) score < 10 who received TACE as initial treatment were analyzed. Predictive factors for overall survival were assessed.

Results

The mean age was 61.5 years, and the median follow‐up was 10.3 years. A high ALBI grade (ALBI score > −2.60) was observed in 147 patients (59%). Multivariable analysis showed that mortality was significantly associated with Barcelona Clinic Liver Cancer (BCLC) stage B (hazard ratio [HR] 2.21, 95% confidence interval [CI] 1.24–3.93, p = 0.007), BCLC stage C (HR 4.80, 95% CI 2.76–8.34, p < 0.001), presence of ascites (HR 2.28, 95% CI 1.31–3.97, p = 0.003), progressive disease (PD) of tumor response (HR 2.95, 95% CI 1.76–4.93, p < 0.001), and high ALBI grade (Grade ≥ 2) (HR 1.96, 95% CI 1.20–3.21, p = 0.008). Overall survival differed significantly by ALBI grade: the 3‐, 6‐, 9‐, and 12‐year survival rates were 80.4%, 78.7%, 76.2%, and 65.5% in the low ALBI group (Grade 1) and 61.3%, 42.8%, 35.7%, and 35.7% in the high ALBI group (Grade ≥ 2) ( p < 0.001).

Conclusions

High ALBI grade (Grade ≥ 2) is associated with increased mortality in patients with Child–Pugh class A and low MELD score undergoing TACE for HCC. ALBI grade may serve as a predictor of survival in patients with preserved liver function receiving TACE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsChemoembolization, TherapeuticBilirubinSerum AlbuminHumansMaleFemaleMiddle AgedAgedTime FactorsPredictive Value of TestsFollow-Up StudiesSurvival RateBiomarkersSerum Albumin, HumanRetrospective Studies

Stichwörter der Autor:innen

ALBI gradeChild–Pugh class Ahepatocellular carcinomatransarterial chemoembolization

Substanzen

BilirubinSerum AlbuminBiomarkersSerum Albumin, Human

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

ORCID-Profile: Kyoung A Ko, Won Sohn

Zitieren

APA

Ko, K. A., Oh, H., Kim, M. S., Hong, H. P., Cho, Y. K., Kim, B. I., & Sohn, W. (2025). Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70098

Vancouver

Ko KA, Oh H, Kim MS, Hong HP, Cho YK, Kim BI, et al. Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.70098

BibTeX
@article{Ko2025,
  author = {Ko, Kyoung A and Oh, Hyunwoo and Kim, Myung Sub and Hong, Hyun Pyo and Cho, Yong Kyun and Kim, Byung Ik and Sohn, Won},
  title = {Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.70098}
}
Kostenlos starten →